Product Reports Resources Pricing Login Book a demo

908 Devices

Biotech & Life Sciences · Broadway, United States · Founded 2012 · IPO 2021

908 Devices is a pioneering company in the field of chemical and biochemical analysis, offering innovative solutions that span multiple industries. Their primary focus is on life science research, biopharmaceuticals, and forensics. The company’s technology is designed to provide rapid, accurate, and actionable data, which is crucial for making informed decisions in critical applications. 908 Devices serves a diverse range of clients, including academic researchers, pharmaceutical companies, forensic laboratories, and government agencies. These clients rely on 908 Devices' products to streamline their analytical processes, reduce time-to-results, and enhance the accuracy of their data. Operating in the analytical instrumentation market, 908 Devices has carved out a niche by developing both handheld and desktop devices that simplify complex chemical analyses. Their flagship products, such as the REBEL and ZipChip, are designed to provide near real-time data and significantly reduce analysis times. For example, the REBEL device offers instant amino acid profiling, allowing users to make process decisions during experiments. Similarly, the ZipChip device enhances sample preparation and separation, enabling faster and more efficient metabolomic and proteomic analyses. The business model of 908 Devices revolves around the sale of these advanced analytical instruments, along with associated consumables and software. They generate revenue through direct sales, as well as through service contracts and maintenance agreements. By offering cutting-edge technology that improves the efficiency and effectiveness of chemical analysis, 908 Devices provides significant value to its clients, which in turn drives its financial performance. In summary, 908 Devices is revolutionizing the field of chemical and biochemical analysis with its innovative, user-friendly products that deliver rapid and reliable results. Their commitment to making a difference in critical applications sets them apart in the industry. Keywords: chemical analysis, biochemical analysis, life science, biopharmaceuticals, forensics, handheld devices, desktop devices, rapid data, metabolomics, proteomics.

Valuation $100–500M
Revenue $50–100M
Headcount 100–500
Total funding $50–100M

Investors

8 investors on 908 Devices's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 3 investors entered at this stage
Series B+ 5 investors entered at this stage
Aramco Ventures
Tao Capital Partners
Casdin Capital
Cormorant Asset Management
Northpond Ventures

Global footprint

Where 908 Devices has talent and traffic

Workforce by country
8 countries with
team presence
🇺🇸 United States94.6%
🇬🇧 United Kingdom0.8%
🇦🇪 United Arab Emirates0.8%
🇩🇪 Germany0.8%
🇳🇱 Netherlands0.8%
Top 5 of 8 shown
Web traffic by country
17K monthly visits
across markets
🇺🇸 United States71.2%
🇬🇧 United Kingdom9.4%
🇨🇦 Canada9.4%
🇮🇳 India5.9%
🇳🇬 Nigeria2.4%
Top 5 markets shown

Talent graph

The shape of 908 Devices's talent

Dealroom maps 908 Devices's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

20 team members profilednamed & role-tagged by Dealroom
210 employeestotal headcount
7 executives & foundersidentified by name
DimensionScore
AI Talent Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock 908 Devices's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Market sentiment

What the market is saying about 908 Devices

An AI-synthesized read of the highest-engagement posts about 908 Devices on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See 908 Devices on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.